selected publications
- First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2025 Academic Article GET IT
-
Therapeutic antibody activation of the glucocorticoid-induced TNF receptor by a clustering mechanism.
Science advances.
2022
Academic Article
GET IT
Times cited: 9 -
Cyclophosphamide enhances the antitumor potency of GITR engagement by increasing oligoclonal cytotoxic T cell fitness.
JCI insight.
2021
Academic Article
GET IT
Times cited: 5 -
CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours.
Nature.
2021
Academic Article
GET IT
Times cited: 331 -
Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.
Advances in experimental medicine and biology.
2021
Academic Article
GET IT
Times cited: 7 -
Interacting Genetic Lesions of Melanoma in the Tumor Microenvironment: Defining a Viable Therapy.
Advances in experimental medicine and biology.
2021
Academic Article
GET IT
Times cited: 1 -
Ethanol Enhances Estrogen Mediated Angiogenesis in Breast Cancer.
Journal of Cancer.
2018
Academic Article
GET IT
Times cited: 8 -
Corrigendum to "Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation" [J. Mol. Cell. Cardiol. 117 (2018) 88-99].
2018
GET IT
Times cited: 1 -
Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer.
Oncotarget.
2018
Academic Article
GET IT
Times cited: 37 -
Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation.
Journal of molecular and cellular cardiology.
2018
Academic Article
GET IT
Times cited: 27